PREVALENCE AND CLINICAL SPECIMEN DISTRIBUTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AT JEMURSARI ISLAMIC HOSPITAL SURABAYA IN 2020
DOI:
https://doi.org/10.62354/jurnalmedicare.v5i4.545Abstract
Background: Methicillin-Resistant Staphylococcus aureus (MRSA) represents a critical pathogen responsible for healthcare-associated infections (HAIs), posing formidable therapeutic challenges due to acquired resistance against nearly all β-lactam antibiotics via PBP2a production. Routine microbiological surveillance in secondary and tertiary referral hospitals is imperative to formulate institutional antibiograms and guide rational empirical antimicrobial regimens.
Objective: To determine the prevalence of MRSA among clinical Staphylococcus aureus isolates and analyze its distribution across specimen types and patient age brackets at Jemursari Islamic Hospital Surabaya during 2020. Methods: A descriptive retrospective cross-sectional study was conducted utilizing secondary laboratory culture databases and medical records from the Clinical Pathology Laboratory of Jemursari Islamic Hospital Surabaya between January and December 2020. All confirmed Staphylococcus aureus isolates fulfilling inclusion criteria were analyzed. Variables evaluated encompassed methicillin-resistance phenotypes (MSSA vs. MRSA), clinical specimen origins, and patient age strata. Data were synthesized using frequency distributions and relative percentages.
Results: A total of 23 non-duplicate Staphylococcus aureus isolates were identified across the one-year surveillance window. Methicillin-Sensitive Staphylococcus aureus (MSSA) accounted for 17 isolates (73.9%), while Methicillin-Resistant Staphylococcus aureus (MRSA) comprised 6 isolates, establishing an overall institutional MRSA prevalence of 26.1%. Stratified by clinical specimen type, MRSA isolates were predominantly recovered from pus/wound exudates (66.7%, n = 4), followed by sputum specimens (33.3%, n = 2). Age-stratified analysis revealed that MRSA was most frequently recovered from older adult patients aged 51–60 years (33.3%, n = 2), with single isolates (16.7% each) identified in age groups 11–20, 21–30, 31–40, and 61–70 years.
Conclusion: The prevalence of MRSA at Jemursari Islamic Hospital Surabaya in 2020 was 26.1%, predominantly originating from purulent soft tissue and respiratory specimens in older adult inpatients. Continuous microbiological surveillance, implementation of strict antimicrobial stewardship programs (ASP), and rigorous infection prevention and control (IPC) protocols are vital to curb the transmission of resistant clones.
Downloads
Keywords:
Antimicrobial resistance, Hospital infection, Inpatient care, Methicillin-Resistant Staphylococcus aureus (MRSA), Pus specimen, SurveillanceReferences
Alni, R. H., Mohammadzadeh, A., Mahmoodi, P., & Alikhani, M. Y. (2018). Detection of toxic shock syndrome toxin (TSST) gene among Staphylococcus aureus isolated from patients and healthy carriers. Avicenna Journal of Clinical Microbiology and Infection, 5(1), 1–5. https://doi.org/10.34172/ajcmi.2018.01
Boswihi, S. S., & Udo, E. E. (2018). Methicillin-resistant Staphylococcus aureus: An update on the epidemiology, treatment options, and infection control. Current Medicine Research and Practice, 8(1), 18–24. https://doi.org/10.1016/j.cmrp.2018.01.001
Budiman, H. M., Soleha, T. U., Warganegara, E., & Anggraini, D. I. (2020). Prevalence of colonization of methicillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit (ICU) of Abdul Moeloek General Hospital, Bandar Lampung. Majority, 9(1), 19–23.
Chineko, S. I., Pratiwi, D. I. N., Rahmiati, R., Muthmainnah, N., & Yasmina, A. (2021). Antibiotic susceptibility pattern of MRSA in the intensive care unit of Ulin General Hospital Banjarmasin. Indonesian Journal of Clinical Pathology and Medical Laboratory, 27(2), 177–183. https://doi.org/10.24293/ijcpml.v27i2.1702
David, M. Z., & Daum, R. S. (2010). Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clinical Microbiology Reviews, 23(3), 616–687. https://doi.org/10.1128/CMR.00081-09
Garoy, E. Y., Gebreab, Y. B., Achila, O. O., Tekeste, D. G., Kesete, R., Ghirmay, R., Kiflay, R., & Tesfu, T. (2019). Methicillin-resistant Staphylococcus aureus (MRSA): Prevalence and antimicrobial sensitivity pattern among patients—A multicenter study in Asmara, Eritrea. Canadian Journal of Infectious Diseases and Medical Microbiology, 2019, Article 8321834. https://doi.org/10.1155/2019/8321834
Kock, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J., Mielke, M., Peters, G., Skov, R. L., Struelens, M. J., Tacconelli, E., Navarro Torné, A., Witte, W., & Friedrich, A. W. (2010). Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Eurosurveillance, 15(41), Article 19688. https://doi.org/10.2807/ese.15.41.19688-en
Kumar, P., Gupta, G., Gupta, G. K., Mishra, V., & Gupta, G. (2021). Prevalence of MRSA and antimicrobial susceptibility of Staphylococcus aureus in clinical samples in the National Capital Region, India. Journal of Pharmaceutical Research International, 33(59A), 209–215. https://doi.org/10.9734/jpri/2021/v33i59A34289
Lakhundi, S., & Zhang, K. (2018). Methicillin-resistant Staphylococcus aureus: Molecular characterization, evolution, and epidemiology. Clinical Microbiology Reviews, 31(4), Article e00020-18. https://doi.org/10.1128/CMR.00020-18
Nismawati, N., Sjahril, R., & Agus, R. (2018). Detection of methicillin-resistant Staphylococcus aureus (MRSA) in patients of Hasanuddin University Hospital using culture methods. Proceedings of the National Seminar on Indonesian Megabiodiversity, 1(1), 112–118.
Sutandhio, S., Widodo, A. D. W., & Wasito, E. B. (2018). Distribution and antibiogram of MRSA from blood specimens in four semesters perspective in Dr. Soetomo General Hospital Surabaya. Jurnal Widya Medika, 4(2), 61–67.
Syahniar, R., Rayhana, R., Swasti, K. D., Khatam, M., & Duarsa, D. B. B. (2020). Methicillin-resistant Staphylococcus aureus among clinical isolates in Indonesia: A systematic review. Biomedical & Pharmacology Journal, 13(4), 1871–1878. https://doi.org/10.13005/bpj/2064
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., Ouellette, M., Outterson, K., Patel, J., Cavaleri, M., Cox, E. M., Houchens, C. R., Grayson, M. L., Hansen, P., Singh, N., … Zorzet, A. (2018). Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases, 18(3), 318–327. https://doi.org/10.1016/S1473-3099(17)30753-3
Thirafi, S. Z. T., Bramantono, B., & Kuntaman, K. (2017). Susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) bacteria in Dr. Soetomo General Academic Hospital Surabaya, Indonesia (Master's thesis). Universitas Airlangga Repository.
Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015). Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and novel therapeutics. Clinical Microbiology Reviews, 28(3), 603–661. https://doi.org/10.1128/CMR.00134-14
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019). Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nature Reviews Microbiology, 17(4), 203–218. https://doi.org/10.1038/s41579-018-0147-4
Vestergaard, M., Frees, D., & Ingmer, H. (2019). Antibiotic resistance and the MRSA problem. Microbiology Spectrum, 7(2), 1–23. https://doi.org/10.1128/microbiolspec.GPP3-0057-2018
World Health Organization. (2023). Global antimicrobial resistance and use surveillance system (GLASS) report 2022. World Health Organization. https://www.who.int/publications/i/item/9789240062702
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jurnal Medicare

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Licensing for Data Publication
-
Open Data Commons Attribution License, http://www.opendatacommons.org/licenses/by/1.0/ (default)
-
Creative Commons CC-Zero Waiver, http://creativecommons.org/publicdomain/zero/1.0/
-
Open Data Commons Public Domain Dedication and Licence, http://www.opendatacommons.org/licenses/pddl/1-0/












